Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day

Dow Jones03-25

DJ Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ slipped 1.27% to $125.60 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.16% to 5,776.65 and the Dow Jones Industrial Average rising 0.01% to 42,587.50.

Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th.

Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.39% to $161.02, Pfizer Inc. $(PFE)$ fell 2.26% to $25.55, and Merck & Co. Inc. $(MRK)$ fell 4.81% to $87.87.

Trading volume (6.2 M) remained 906,118 below its 50-day average volume of 7.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 25, 2025 16:33 ET (20:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2522383918?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-26 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522383918","market":"nz","top_or_hot":-1,"title":"Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Abbott Laboratories <a href=\"https://laohu8.com/S/ABT\">$(ABT)$</a> slipped 1.27% to $125.60 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50. \n</p>\n<p>\n     Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.39% to $161.02, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 2.26% to $25.55, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> fell 4.81% to $87.87. \n</p>\n<p>\n     Trading volume (6.2 M) remained 906,118 below its 50-day average volume of 7.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbbott Laboratories Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-26 04:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Abbott Laboratories <a href=\"https://laohu8.com/S/ABT\">$(ABT)$</a> slipped 1.27% to $125.60 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50. \n</p>\n<p>\n     Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.39% to $161.02, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 2.26% to $25.55, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> fell 4.81% to $87.87. \n</p>\n<p>\n     Trading volume (6.2 M) remained 906,118 below its 50-day average volume of 7.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABT","symbol_name":"雅培","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2522383918","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522383918","pubTimestamp":1742934780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  slipped 1.27% to $125.60 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50.Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 1.39% to $161.02, Pfizer Inc.  fell 2.26% to $25.55, and Merck & Co. Inc.  fell 4.81% to $87.87.Trading volume  remained 906,118 below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"ABT":"雅培"},"translate_title":"尽管当天下跌，雅培实验室股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1},"content_text":"DJ Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Abbott Laboratories $(ABT)$ slipped 1.27% to $125.60 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50. \n\n\n     Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th. \n\n\n     Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.39% to $161.02, Pfizer Inc. $(PFE)$ fell 2.26% to $25.55, and Merck & Co. Inc. $(MRK)$ fell 4.81% to $87.87. \n\n\n     Trading volume (6.2 M) remained 906,118 below its 50-day average volume of 7.1 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 16:33 ET (20:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2522383918"}